The tweet was deleted by the author.
But we saved everything 🙂.
Zymeworks, a leader in biotechnology, is making strides in oncology with its novel approach to combination therapies. Presenting at the Biotech Showcase, Adam Schayowitz, Acting Chief Development Officer of Zymeworks, emphasized the importance of innovation in developing effective cancer treatments. He highlighted the company's expertise in protein engineering as crucial to forging the future of oncology. Zymeworks is committed to differentiating itself by leveraging its world-class expertise to create therapies that can make a significant impact on patient care and outcomes.